Bekir Ö. A case of Non-Obstructive type Azoospermia. In other words, it is a case of production type azoospermia that is difficult to treat. Bekir had previously received dialysis due to chronic kidney failure. After undergoing dialysis for a while, he had a kidney transplant.
Now I want to express one more point here. In order to prevent the kidney from being rejected by the body, some drugs need to be given in the setting of chemotherapy. Since he also takes these, our efforts to cure the dormant stem cell with stem cell regeneration therapy will of course not reach their full target.
This is where we must be very careful when making adjustments to phytotherapy and antioxidant therapy with other drugs. Despite Bekir’s transplanted kidney, his creatinine was above normal and his body was very edematous. When I gave him couch grass extract, the edema resolved and he not only lost weight; Additionally, creatinine decreased to normal values. He also had problems due to urethral obstruction and had to undergo surgery for dilation (expansion) many times. At that time, in our opinion, Bekir was a patient who not only had production-type azoospermia but also had a conduction-type problem. We also had to have this procedure done once. Because the volume was low, we were not able to analyze the semen in detail. His treatment lasted just over a year and a half.
We stated that it was too early for Micro TESE, but he could not be patient and had surgery. Thank God, he got his wish and enough sperm was found. His wife became pregnant with micro ICSI and their beautiful child was welcomed into the world.
We discussed his cell detail from scratch (Spermatocyte) and gave the treatment according to the semen detail, seeing that there was a progression from the first step to the seventh step, which has the best qualities in elonge, that is, just one step before the sperm. For the Micro TESE decision, if there is no normal outcome with treatment, we allow our patients to undergo surgery if the last four tests maintain the same pattern. Sometimes we find it healthier for them to make their own decisions by saying either yes or no of their own accord.
Both the studies of Foresta and his colleagues at the University of Padova in Italy and the studies of Paul Tureck and his team in the USA, just like us, acted according to the prediction of detailed semen analysis by entering the patients at the appropriate time and in the right place (some radiological and micro biopsies were performed in the places where the sperm output is highest). In a sense, the determination steps) and the estimated region mapping efforts with the chance of sperm emergence, preparing for the operation are exemplary studies of what we do in the world.
However, no matter what you do over time, the scientific world, which has seen an increase in the rate of cases in which the spermatid never matures and gets stuck in the process we call maturation arrest, has shown the contribution of many congenital or acquired genetic disorders to this process, and in current publications, especially on a cellular and genetic basis, these predictive analyzes are carried out without making them. Calling the micro TESE procedure as in-effective TESE, in a sense, in our words, it is short-sighted and treatmentless, and also expressing that they do not find hasty TESE approaches healthy, statements that such TESE approaches should be avoided are rapidly increasing, and Gonadotropin-based treatments as we provide are clearly in this situation. It is emphasized that its success is superior to that of micro TESE.
